Chris Achar
Director/Board Member at CUE HEALTH INC.
Net worth: 293 307 $ as of 30/04/2024
Profile
Chris K.
Achar is currently the Chief Executive Officer at GenZum Life Sciences LLC and Genzum Life Sciences, Inc. He is also the Director and Chief Strategy Officer at Cue Health, Inc. and the Director at The Network for Teaching Entrepreneurship.
Achar completed his undergraduate degree at The California State University and his MBA at Pepperdine Graziadio Business School.
Known holdings in public companies
Company | Date | Number of shares | Valuation | Valuation date |
---|---|---|---|---|
CUE HEALTH INC.
1.27% | 31/03/2024 | 2,008,950 ( 1.27% ) | 293 307 $ | 30/04/2024 |
Chris Achar active positions
Companies | Position | Start |
---|---|---|
CUE HEALTH INC. | Director/Board Member | 01/05/2018 |
Genzum Life Sciences, Inc. | Chief Executive Officer | 01/01/2020 |
The Network for Teaching Entrepreneurship
The Network for Teaching Entrepreneurship Miscellaneous Commercial ServicesCommercial Services The Network for Teaching Entrepreneurship (NFTE) is a non-profit organization that provides entrepreneurship education to middle school, high school, and postsecondary students in 30 states and 31 countries. The non-profit company is based in New York, NY. NFTE aims to ignite the entrepreneurial mindset in students, empowering them to own their futures regardless of their family income, community resources, special needs, gender identity, race, or ethnicity. NFTE has educated over a million students through in-school, out-of-school, in-person, online, or hybrid programs. The company was founded in 1987 by Carl Press and Philip A. McNeill, and J.D. LaRock has been the CEO of the company since 2019. | Director/Board Member | 01/01/2018 |
GenZum Life Sciences LLC
GenZum Life Sciences LLC Pharmaceuticals: MajorHealth Technology GenZum Life Sciences LLC operates as a pharmaceutical product development and out licensing company. It operates throughout the pharmaceutical development cycle and from product selection and formulation to clinical trials and FDA approval, Genzum product lines have been in-licensed by pharmaceutical companies, decreasing costs, increasing market value and improving the lives of many. The firm utilizes an innovative ecosystem of best in class facilities and expert pharmaceutical development and clinical trials capabilities. The company was founded by Rajin K. Ahuja and Chris K. Achar in 2008 and is headquartered in Los Angeles, CA. | Chief Executive Officer | 01/01/2010 |
Training of Chris Achar
The California State University | Undergraduate Degree |
Pepperdine Graziadio Business School | Masters Business Admin |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 1 |
---|---|
CUE HEALTH INC. | Health Technology |
Private companies | 3 |
---|---|
The Network for Teaching Entrepreneurship
The Network for Teaching Entrepreneurship Miscellaneous Commercial ServicesCommercial Services The Network for Teaching Entrepreneurship (NFTE) is a non-profit organization that provides entrepreneurship education to middle school, high school, and postsecondary students in 30 states and 31 countries. The non-profit company is based in New York, NY. NFTE aims to ignite the entrepreneurial mindset in students, empowering them to own their futures regardless of their family income, community resources, special needs, gender identity, race, or ethnicity. NFTE has educated over a million students through in-school, out-of-school, in-person, online, or hybrid programs. The company was founded in 1987 by Carl Press and Philip A. McNeill, and J.D. LaRock has been the CEO of the company since 2019. | Commercial Services |
GenZum Life Sciences LLC
GenZum Life Sciences LLC Pharmaceuticals: MajorHealth Technology GenZum Life Sciences LLC operates as a pharmaceutical product development and out licensing company. It operates throughout the pharmaceutical development cycle and from product selection and formulation to clinical trials and FDA approval, Genzum product lines have been in-licensed by pharmaceutical companies, decreasing costs, increasing market value and improving the lives of many. The firm utilizes an innovative ecosystem of best in class facilities and expert pharmaceutical development and clinical trials capabilities. The company was founded by Rajin K. Ahuja and Chris K. Achar in 2008 and is headquartered in Los Angeles, CA. | Health Technology |
Genzum Life Sciences, Inc. |
- Stock Market
- Insiders
- Chris Achar